Dominique P. Monnet was appointed to the position of president of PDL BioPharma Inc.

Greg Flynn was tapped as regional president of Ashfield Commercial and Clinical businesses in the United States. Flynn transitioned to this role from his position as regional president in Japan and representative director of CMIC Ashfield.

Two VPs have been named at TGaS Advisors. Tom Goga has been named to lead Field Operations, which also includes Incentive Compensation, and Rich Waite will head Commercial Learning & Development.

Debra K. Bowes has joined MaxCyte Inc. as executive VP, Business and Strategic Development.

Fredrik Wiklund has been made chief operating officer of Bioniz Therapeutics Inc.

Yutaka Niihara, M.D., MPH, has been reapppointed CEO of Emmaus Life Sciences Inc. Dr. Niihara is co-founder and chairman of the company. Emmaus Life Sciences is engaged in the discovery, development and commercialization of innovative treatments and therapies for rare and orphan diseases.